SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page678910111213Next Page
2026-04-28ARMP3Armata Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership
This filing is an initial statement of beneficial ownership for Daniel B. Gilmer, reporting owner and director at Armata Pharmaceuticals, Inc. The filing, dated April 28, 2026, pertains to the period of report ending April 24, 2026. It indicates that Mr. Gilmer does not beneficially own any securities of the company as...
Small CapBiotechnology
Previous Page678910111213Next Page